Rosell, R <br/><br/>
Predicting response to paclitaxel/carboplatin-based therapy in non-small cell lung cancer.  [electronic resource] 

 -  Seminars in oncology  Aug 2001 
 - 37-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>0093-7754 
<br/><br/><label>Standard No.: </label>10.1016/s0093-7754(01)90058-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carboplatin--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Clinical Trials as Topic<br/>DNA, Neoplasm--blood<br/>Drug Evaluation, Preclinical<br/>Drug Resistance, Neoplasm<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Paclitaxel--administration & dosage<br/>Tubulin--genetics